Independent register of U.S. FDA drug recalls · updated Oct 14, 2026
RxRecalls Get alerts

Class II drug recalls - moderate risk

Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.

14,543 recalls, newest first.

Class II · Moderate risk

Clopidogrel Tablets

Failed dissolution specification -Two additional lots being recalled due to Out-of-Specification results observed for dissolution at 18th month stability testing.

Terminated Dissolution failure Dr. Reddy's Laboratories, Inc. NDC 55111-671-31 D-0294-2019
Class II · Moderate risk

Valsartan and Hydrochlorothiazide Tablets

GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.

Ongoing Nitrosamine impurity Mylan Laboratories Limited, (Nashik FDF) NDC 0378-6325-77 D-0332-2019
Class II · Moderate risk

Valsartan and Hydrochlorothiazide Tablets

GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.

Ongoing Nitrosamine impurity Mylan Laboratories Limited, (Nashik FDF) NDC 0378-6324-77 D-0331-2019
Class II · Moderate risk

Valsartan and Hydrochlorothiazide Tablets

GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.

Ongoing Nitrosamine impurity Mylan Laboratories Limited, (Nashik FDF) NDC 0378-6323-77 D-0330-2019

Recalls by year